bevacizumab
Avastin™
Anti-VEGF therapeutic monoclonal antibody.
Bevacizumab is an antiangiogenesis drug, used in molecular targeted therapy to stop tumors from making new blood vessels.
Bevacizumab is approved for use against metastatic colorectal cancer, and is being studied for the treatment of many different cancers.